Skip to main content
Top
Published in: Reactions Weekly 1/2015

01-04-2015 | Case report

Antineoplastics/ciclosporin

Post-transplant lymphoproliferative disorder, renal toxicity and hypertension: case report

Published in: Reactions Weekly | Issue 1/2015

Login to get access

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literature
go back to reference Basso S, et al. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient. Pediatric Transplantation 17: E168-73, No. 7, Nov 2013. Available from: URL: http://doi.org/10.1111/petr.12146 - ItalyPubMed Basso S, et al. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient. Pediatric Transplantation 17: E168-73, No. 7, Nov 2013. Available from: URL: http://​doi.​org/​10.​1111/​petr.​12146 - ItalyPubMed
Metadata
Title
Antineoplastics/ciclosporin
Post-transplant lymphoproliferative disorder, renal toxicity and hypertension: case report
Publication date
01-04-2015
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2015
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-9123-1

Other articles of this Issue 1/2015

Reactions Weekly 1/2015 Go to the issue

Case report

Telaprevir

Case report

Methotrexate

Case report

Antituberculars

Case report

Silver

Case report

Lamotrigine

Case report

Mercaptopurine